|
1
|
Yan M and Liu Q: Differentiation therapy:
A promising strategy for cancer treatment. Chin J Cancer. 35:32016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vinogradov S and Wei X: Cancer stem cells
and drug resistance: The potential of nanomedicine. Nanomedicine
(Lond). 7:597–615. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Codony-Servat J and Rosell R: Cancer stem
cells and immunoresistance: Clinical implications and solutions.
Transl Lung Cancer Res. 4:689–703. 2015.PubMed/NCBI
|
|
4
|
Sultan M, Coyle KM, Vidovic D, Thomas ML,
Gujar S and Marcato P: Hide-and-seek: The interplay between cancer
stem cells and the immune system. Carcinogenesis. 38:107–118. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee Y and Sunwoo J: PD-L1 is
preferentially expressed on CD44+ tumor-initiating cells
in head and neck squamous cell carcinoma. J Immunother Cancer. 2
(Suppl):2702014. View Article : Google Scholar
|
|
6
|
Brahmer JR, Tykodi SS, Chow LQ, Hwu WJ,
Topalian SL, Hwu P, Drake CG, Camacho LH, Kauh J, Odunsi K, et al:
Safety and activity of anti-PD-L1 antibody in patients with
advanced cancer. N Engl J Med. 366:2455–2465. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
LeMaoult J, Caumartin J, Daouya M, Favier
B, Le Rond S, Gonzalez A and Carosella ED: Immune regulation by
pretenders: Cell-to-cell transfers of HLA-G make effector T cells
act as regulatory cells. Blood. 109:2040–2048. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ullah M, Azazzen D, Kaci R, Benabbou N,
Pujade Lauraine E, Pocard M and Mirshahi M: High expression of
HLA-G in ovarian carcinomatosis: The role of interleukin-1β.
Neoplasia. 21:331–342. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yie SM, Yang H, Ye SR, Li K, Dong DD and
Lin XM: Expression of human leucocyte antigen G (HLA-G) is
associated with prognosis in non-small cell lung cancer. Lung
Cancer. 58:267–274. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cai MB, Han HQ, Bei JX, Liu CC, Lei JJ,
Cui Q, Feng QS, Wang HY, Zhang JX, Liang Y, et al: Expression of
human leukocyte antigen G is associated with prognosis in
nasopharyngeal carcinoma. Int J Biol Sci. 8:891–900. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kirana C, Ruszkiewicz A, Stubbs RS,
Hardingham JE, Hewett PJ, Maddern GJ and Hauben E: Soluble HLA-G is
a differential prognostic marker in sequential colorectal cancer
disease stages. Int J Cancer. 140:2577–2586. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tang Y, Fang W, Zhang Y, Hong S, Kang S,
Yan Y, Chen N, Zhan J, He X, Qin T, et al: The association between
PD-L1 and EGFR status and the prognostic value of PD-L1 in advanced
non-small cell lung cancer patients treated with EGFR-TKIs.
Oncotarget. 6:14209–14219. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Inamura K, Yokouchi Y, Sakakibara R,
Kobayashi M, Subat S, Ninomiya H, Nagano H, Nomura K, Okumura S and
Ishikawa Y: Relationship of tumor PD-L1 expression with EGFR
wild-type status and poor prognosis in lung adenocarcinoma. Jpn J
Clin Oncol. 46:935–941. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mu CY, Huang JA, Chen Y, Chen C and Zhang
XG: High expression of PD-L1 in lung cancer may contribute to poor
prognosis and tumor cells immune escape through suppressing tumor
infiltrating dendritic cells maturation. Med Oncol. 28:682–688.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xiang X, Yu PC, Long D, Liao XL, Zhang S,
You XM, Zhong JH and Li LQ: Prognostic value of PD-L1 expression in
patients with primary solid tumors. Oncotarget. 9:5058–5072.
2017.PubMed/NCBI
|
|
16
|
Sorensen SF, Zho W, Dolled-Filhart M,
Georgsen JB, Wang Z, Emancipator K, Wu D, Busch-Sørensen M,
Meldgaard P and Hager H: PD-L1 expression and survival among
patients with advanced non-small cell lung cancer treated with
chemotherapy. Transl Oncol. 9:64–69. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gu L, Chen M, Guo D, Zhu H, Zhang W, Pan
J, Zhong X, Li X, Qian H and Wang X: PD-L1 and gastric cancer
prognosis: A systematic review and meta-analysis. PLoS One.
12:e01826922017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Grignani F, Ferrucci PF, Testa U, Talamo
G, Fagioli M, Alcalay M, Mencarelli A, Grignani F, Peschle C,
Nicoletti I, et al: The acute promyelocytic leukemia-specific
PML-RARα fusion protein inhibits differentiation and promotes
survival of myeloid precursor cells. Cell. 74:423–431. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Su M, Alonso S, Jones JW, Yu J, Kane MA,
Jones RJ and Ghiaur G: All-trans retinoic acid activity in acute
myeloid leukemia: Role of cytochrome P450 enzyme expression by the
microenvironment. PLoS One. 10:e01277902015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shah S, Pocard M and Mirshahi M: Targeting
the differentiation of gastric cancer cells (KATO-III)
downregulates epithelial-mesenchymal and cancer stem cell markers.
Oncol Rep. 42:670–678. 2019.PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Eaves CJ: Cancer stem cells: Here, there,
everywhere? Nature. 456:581–582. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kawamata H, Tachibana M, Fujimori T and
Imai Y: Differentiation-inducing therapy for solid tumors. Curr
Pharm Des. 12:379–385. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kaci R, Shahid S, Réa L, Philipe B, Amu T,
Marc P and Massoud MJII: Neural signature expressed by cells from
ovarian carcinoma (A Case Report). J Immunochem Immunopathol.
1:22015.
|
|
25
|
Montespan F, Deschaseaux F, Sensébé L,
Carosella ED and Rouas-Freiss N: Osteodifferentiated mesenchymal
stem cells from bone marrow and adipose tissue express HLA-G and
display immunomodulatory properties in HLA-mismatched settings:
Implications in bone repair therapy. J Immunol Res.
2014:2303462014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Veldhuis-Vlug AG and Rosen CJ: Clinical
implications of bone marrow adiposity. J Intern Med. 283:121–139.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Islam A: Do bone marrow fat cells or their
precursors have a pathogenic role in idiopathic aplastic anaemia?
Med Hypotheses. 25:209–217. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lu W, Weng W, Zhu Q, Zhai Y, Wan Y, Liu H,
Yang S, Yu Y, Wei Y and Shi J: Small bone marrow adipocytes predict
poor prognosis in acute myeloid leukemia. Haematologica.
103:e21–e24. 2018. View Article : Google Scholar : PubMed/NCBI
|
